Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel vaccine offers hope in fight against avian flu
The vaccine reduces the level of avian flu virus chickens shed into the environment.
“Our improved vaccine could help prevent the spread of flu amongst vaccinated birds" - Prof. Munir Iqbal.

A novel vaccine for avian influenza that produces a faster and stronger immune response in chickens compared to current vaccines has been developed by The Pirbright Institute.

The vaccine, reported in the journal npj Vaccines, protects chickens against signs of the H9N2 avian flu strain and reduces the level of virus they shed into the environment. Researchers note an antibody response in chickens as early as six days after they had received the vaccination.

Avian flu vaccines are traditionally produced in chicken eggs. But in this study, researchers made the vaccine in laboratory cultures of insect cells – a technique that makes it easier and less expensive to produce. 

The vaccine works by tagging flu virus proteins with a marker that makes it easier for immune cells, known as Antigen Presenting Cells (APCs), to efficiently capture and process the tagged proteins for triggering an immune response. 

The team specifically tagged the influenza virus haemagglutinin protein (HA) and directed it to target CD83, a protein on the chicken APCs, demonstrating for the first time that this can be used as an effective vaccine. 

“By targeting HA to chicken immune cells, we have generated a powerful addition to the armoury of poultry vaccines,” explained Professor Munir Iqbal, head of Pirbright’s avian influenza virus group. “Our improved vaccine could help prevent the spread of flu amongst vaccinated birds, which is essential for protecting poultry welfare, increasing food production, and reducing the risk of avian influenza spreading to humans.”

As the vaccine does not contain any live flu virus, it is also safer. Researchers say that no specialist high containment facilities are needed for its manufacture – a quality that makes it very attractive for large-scale manufacture.

Work is now underway to assess the vaccine’s potential for commercial production and use in the field.  

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Milk recalled over presence of veterinary medicines

Graham's Family Dairy has issued a recall for its semi-skimmed milk due to the presence of veterinary medicines in the product.

In a risk statement, the Food Standards Agency said the presence of the medicines, including penicillin, make the milk unsafe to consume and 'may be a possible health risk for anyone with an allergy to antibiotics'.

Customers who bought the product are advised to return it to the store of purchase for a full refund.